Xofigo radium 223 radiopharmaceutical
Ended Awarded Last action
- Contract number
- VA25616J0005
- Awardee
-
Bayer Healthcare Pharmaceuticals Inc. UEI V1EVGCK7XES8
- Awarding agency
-
Veterans Integrated Service Network 16
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $226,536
Award facts
- Contract value 59% obligated
-
- $226,536.34 Current, with exercised options
- $385,706.06 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- Funding agency
- Veterans Integrated Service Network 17 Veterans Health Administration, Department of Veterans Affairs
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Wayne, NJ, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$74,116 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $88,427 | |
| Original award | $212,225 |
About this award
This is a federal contract award to Bayer Healthcare Pharmaceuticals Inc., a foreign-owned, for-profit pharmaceutical company, by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 17. The contract is a Delivery Order under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) for the radiopharmaceutical product Xofigo (radium Ra 223 dichloride) used for the treatment of prostate cancer. The contract has a ceiling value of $385,706.06 and a period of performance through December 31, 2016. This award is part of Bayer's larger federal contract portfolio, which includes a $840 million Multiple Award VA Federal Supply Schedule contract and a $45 million Blanket Purchase Agreement with the VA National Acquisition Center for pharmaceutical products. The contract has no set-aside designation.
Quick answers
Who was awarded contract VA25616J0005?
VA25616J0005 was awarded to Bayer Healthcare Pharmaceuticals Inc. by Veterans Integrated Service Network 16 (Veterans Health Administration) on October 1, 2015.
How much is contract VA25616J0005 worth?
The government has obligated $226,536 on VA25616J0005. Its potential value, with all options, is $385,706.
Which agency awarded contract VA25616J0005?
Veterans Integrated Service Network 16 (Veterans Health Administration) awarded VA25616J0005, with funding from Veterans Integrated Service Network 17 (Veterans Health Administration).
Is contract VA25616J0005 an order under another contract?
Yes. VA25616J0005 is a delivery order under V797P2202D, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract VA25616J0005 competed?
The extent of competition for VA25616J0005 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award